Pfizer Subsidiary Recalls Mislabeled Drugs

Law360, New York (March 29, 2011, 5:15 PM EDT) -- A generic-drug maker subsidiary of Pfizer Inc. on Saturday announced the voluntary recall of a drug lot including Citalopram and Finasteride tablets because bottles were mislabeled.

The recall covers medicines with lot number FI0510058-A on the label, which includes bottles of Citalopram 10 mg tablets and Finasteride 5 mg tablets distributed in the U.S., Greenstone LLC said in a statement.

The company asked patients to return bottles of the drugs with that number to a pharmacist.

Greenstone said incorrect labels may have been placed on the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.